Early Dual-Antiplatelet Therapy at the Emergency Department Is Associated with Lower In-Hospital Major Adverse Cardiac Event Risk among Patients with Non-ST-Elevation Myocardial Infarction

Table 2

Patient outcome in each group.

Variable	Time		value
	<6 hours (n = 711)	>6 hours (n = 227)
In-hospital MACE, (%)			0.009
No	686 (96.48)	208 (91.63)
Stroke	3 (0.42)	2 (0.88)
Recurrent MI	0 (0.00)	1 (0.44)
Rupture PCI	1 (0.14)	0 (0.00)
Death	21 (2.95)	16 (7.05)
	25 (3.52)	19 (8.37)
72 hours ED return (%)			0.095
No	705 (99.16)	222 (97.80)
Planned	2 (0.28)	3 (1.32)
Unplanned	4 (0.56)	2 (0.88)
14 days readmission (%)			0.144
No	693 (97.47)	216 (95.15)
Planned	10 (1.41)	5 (2.20)
Unplanned	8 (1.13)	6 (2.64)
PCI performed within 30 days	90 (12.66)	18 (7.93)	0.052^b
CABG performed within 30 days	9 (1.27)	0 (0.00)	0.123^b

a: two-sample T test. b: chi-square test. MACE indicates major adverse cardiovascular disease; MI, myocardial infarction; PCI, percutaneous coronary intervention; ED, emergency department; CABG, coronary artery bypass graft.